Newronika closes €13.6 million funding round following US FDA approval for adaptive DBS trial
Newronika has successfully closed its €13.6 million Series B funding round led by a new investor, Fondazione ENEA Tech e Biomedical, with additional participation...
Ischaemic stroke outcomes with Vivistim paired VNS therapy highlighted at ISC 2025
Microtransponder has announced that neurosurgeon Ronald Benitez (Atlantic Brain and Spine, Morristown, USA) presented safety and outcomes data from the largest, real-world cohort of...
Electrical brain stimulation fails to boost post-stroke motor recovery in multicentre study
Mild electrical brain stimulation—specifically, transcranial direct current stimulation (tDCS)—did not further improve motor recovery in stroke survivors in a multicentre study presented as late-breaking...
Saluda announces new clinical data and multiple award-winning presentations at NANS 2025
Saluda Medical has announced the recent presentation of new clinical data at the 2025 North American Neuromodulation Society (NANS) annual meeting (30 January–1 February,...
